CDXS
Biotechnology · Healthcare
Equibles does not estimate personal net worth.
Get an email with a short summary when Codexis, Inc. publishes a filing, an earnings call transcript or a press release.
Get CDXS alertsThe proxy statement of Codexis, Inc. reports total compensation of $1,123,094 for Stefan Lutz in fiscal 2025, including a base salary of $481,572. Stefan Lutz has spoken on 1 earnings call across 1 company, most recently for Codexis, Inc. on August 11, 2026. Codexis, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Codexis, Inc. includes Alison Moore (CEO and Board Member), Alison Moore, Ph.D. (CEO and CTO), Dr. Stephen Dilly (CEO) and 7 others.
“Thank you, Alison. at Tides U.S. in May, we presented new data demonstrating on how our ecosynthesis manufacturing technology is not only advancing existing, but also unlocking new capabilities for production of siRNA therapeutics.”
Proxy statement
Start not stated–present
Last confirmed April 28, 2026
CDXS
Biotechnology · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Codexis, Inc. (CDXS) | Chief Scientific Officer | $481,572 | $1,123,094 |